Journal of Medicinal Chemistry · 2003 · 78 citations · 26 references
MedicineMedicinal ChemistryPharmacologyBiosensorsCell SignalingStructure-activity RelationshipsAngiogenesisGrowth Factor SignalingLigand BindingChemical Structure-activity RelationshipsGrowth Factor-receptor InteractionsPlasmonic BiosensorsProtein-protein Interactions In BindingSulfated PolysaccharidesSurface Plasmon Resonance AnalysisSurface Plasmon Resonance Binding AnalysisSurface Plasmon Resonance Biosensors
The binding interactions of the phosphosulfomannan anticancer agent PI-88 (1) with the angiogenic growth factors FGF-1, FGF-2, and VEGF were studied by surface plasmon resonance (SPR) on a BIAcore 3000 biosensor. Compared with heparin, PI-88 has at least 11-fold higher affinity for FGF-1 and at least 3-fold higher affinity for VEGF, but at least 13-fold lower affinity for FGF-2. To define the structural features of PI-88 that are important for growth factor binding, several analogues, such as dephosphorylated PI-88 and a sulfated pentasaccharide, were prepared. The binding interactions of these analogues with FGF-1, FGF-2, and VEGF were similarly studied by SPR, and structure-activity relationships were determined.
26
Transplacental Carcinogenesis by Stilbestrol
Judah Folkman · New England Journal of Medicine · 1971 · 2.6K citations
Pharmacy, Oncology, Toxicology +17
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
Thomas Boehm, Judah Folkman, Timothy Browder et al. · Nature · 1997 · 1.7K citations
Medicine, Oncology, Pharmacology +16
A plastid organelle as a drug target in apicomplexan parasites
Maria E. Fichera, David S. Roos · Nature · 1997 · 587 citations
Life Sciences, Biology, Cell Biology +15
Stability and Variability in Competitive Communities
Anthony R. Ives, Kathy L. Gross, Jennifer L. Klug · Science · 1999 · 377 citations
Life Sciences, Biology, Ecology +17